AJP - Heart AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H1226-H1234, 2006. First published November 4, 2005; doi:10.1152/ajpheart.00607.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/3/H1226    most recent
00607.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parent, R.
Right arrow Articles by Lavallée, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parent, R.
Right arrow Articles by Lavallée, M.

Nitroglycerin reduces myocardial oxygen consumption during exercise despite vascular tolerance

Robert Parent,1 Normand Leblanc,2 and Michel Lavallée1

1Department of Physiology, Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; and 2Department of Pharmacology, Center of Biomedical Research Excellence, University of Nevada School of Medicine, Reno, Nevada

Submitted 7 June 2005 ; accepted in final form 28 October 2005

The long-term benefits of nitroglycerin (NTG) therapy are limited by the development of vascular tolerance and endothelial dysfunction in conductance coronary arteries. We have determined whether nitrate tolerance extends to NTG effects on myocardial O2 consumption (MVO2) and the ability of endogenous nitric oxide (NO) to modulate MVO2 during exercise. In chronically instrumented dogs (n = 8), hemodynamic and MVO2 responses to treadmill exercise were measured before, during tolerance (3 and 7 days of NTG delivery), and 7 days after NTG withdrawal. Acute NTG delivery caused a parallel downward shift of the MVO2-triple product (TP) relations and reversed the disproportionate increases in MVO2 caused by the blockade of NO formation. After 7 days of continuous transdermal NTG delivery, vascular tolerance was displayed as a >75% reduction of coronary blood flow (CBF) responses to NTG boluses. Despite vascular nitrate tolerance, MVO2-TP relations were shifted downward compared with pre-NTG exercise. Seven days after NTG withdrawal, vascular responses to boluses of NTG had recovered from tolerance, and MVO2-TP relations during exercise were back to pre-NTG level. At that time, blockade of NO formation failed to alter MVO2-TP relations. Thus NTG caused a sustained reduction of cardiac MVO2, independent of metabolic demand during exercise, despite tolerance of the coronary microcirculation. NTG-induced vascular tolerance and MVO2 reductions were reversible by NTG withdrawal, but endogenous NO-dependent modulation of O2 consumption was severely impaired.

nitrates; exercise; nitric oxide



Address for reprint requests and other correspondence: M. Lavallée, Dept. of Physiology, Pavillon Paul-G Desmarais, C.P 6128, succursale Centre-ville, Montréal (Québec) H3C 3J7, Canada (e-mail: michel.lavallee{at}umontreal.ca)




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
D. J. Duncker and R. J. Bache
Regulation of Coronary Blood Flow During Exercise
Physiol Rev, July 1, 2008; 88(3): 1009 - 1086.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.